| Feature | Specification |
|---|---|
| Unit Size | 1 vial (10 doses) |
| Specificity | Neutrophil Elastase |
IVISense Neutrophil Elastase 680 FAST™ is a member of a family of activatable fluorescent imaging agents comprising a novel architecture, termed F.A.S.T. (Fluorescent Activatable Sensor Technology) that confers an improved pharmacokinetic profile with a broader range of early imaging time points. This architecture also offers higher target specific signal with reduced background.
This NIR agent is a neutrophil elastase activatable agent that is optically silent upon injection and produces fluorescent signal after cleavage by elastase produced by neutrophil cells. Neutrophil elastase is a key protease involved in acute lung injury, acute respiratory distress syndrome, as well as many other inflammatory processes such as emphysema, cystic fibrosis, COPD, wound healing, rheumatoid arthritis, ischemia-reperfusion and many others.
IVISense Neutrophil Elastase 680 FAST fluorescent imaging agent is a selective neutrophil elastase-activatable agent designed for imaging of this serine protease both in vitro and in vivo. The half-life in plasma of Neutrophil Elastase 680 FAST is 4 hours.
| Brand |
IVISense
|
|---|---|
| Fluorescent Agent Type |
Enzyme activated
|
| Imaging Modality |
Fluorescence
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Specificity |
Neutrophil Elastase
|
| Storage Conditions |
-30 to -16 °C
|
| Therapeutic Area |
Inflammation
|
| Unit Size |
1 vial (10 doses)
|
| Wave Length |
680 nm
|
Are you looking for resources, click on the resource type to explore further.
Researchers trust our in vivo imaging solutions to give them reliable, calibrated data that reveals pathway characterization and...
We are here to answer your questions.